Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients.
about
Associations of fish oil and vitamin B and E supplementation with cardiovascular outcomes and mortality in people receiving haemodialysis: a reviewDHA supplementation: current implications in pregnancy and childhoodModified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic ToxinsAssociations of very high intakes of eicosapentaenoic and docosahexaenoic acids with biomarkers of chronic disease risk among Yup'ik EskimosNatural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapyMaternal docosahexaenoic acid supplementation decreases lung inflammation in hyperoxia-exposed newborn mice.IL-1β receptor antagonist reduces inflammation in hemodialysis patientsExpression profile of polyunsaturated fatty acids in colorectal cancer.Effect of omega-3 fatty acid supplementation on serum lipids and vascular inflammation in patients with end-stage renal disease: a meta-analysis.Optimal nutrition in hemodialysis patients.Associations between Serum Omega-3 Fatty Acid Levels and Cognitive Functions among Community-Dwelling Octogenarians in Okinawa, Japan: The KOCOA Studygamma-Tocopherol nebulization by a lipid aerosolization device improves pulmonary function in sheep with burn and smoke inhalation injury.Essential fatty acids and dietary stress.Atherosclerosis in chronic kidney disease: the role of macrophagesTargeted complement inhibition as a promising strategy for preventing inflammatory complications in hemodialysis.Can treating persistent inflammation limit protein energy wasting?Clinical and research markers of oxidative stress in chronic kidney disease.Antioxidant modulation of F2-isoprostanes in humans: a systematic review.Can metabolically healthy obesity be explained by diet, genetics, and inflammation?Special Issue on "Analytical Methods for Oxidized Biomolecules and Antioxidants" The use of isoprostanoids as biomarkers of oxidative damage, and their role in human dietary intervention studies.Effects of omega-3 fatty acid plus alpha-tocopherol supplementation on malnutrition-inflammation score, biomarkers of inflammation and oxidative stress in chronic hemodialysis patients.Potential effects of omega-3 fatty acids on anemia and inflammatory markers in maintenance hemodialysis patients.Inflammation as a target for improving health in chronic kidney disease.Circulating plasma antioxidants, inflammatory markers and asymptomatic carotid atherosclerosis in end-stage renal disease patients: a case control study.Fish oil supplementation lowers C-reactive protein levels independent of triglyceride reduction in patients with end-stage renal disease.Scientific Opinion on the Tolerable Upper Intake Level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA)Effects of Omega-3 Fatty Acids on Markers of Inflammation in Patients With Chronic Kidney Disease: A Controversial Issue.Malnutrition in Dialysis Patients--The Need for Intervention Despite Uncertain Benefits.Effects of rosa mosqueta oil supplementation in lipogenic markers associated with prevention of liver steatosis.The effect of omega-3 fatty acids on depressive symptoms and inflammatory markers in maintenance hemodialysis patients: a randomized, placebo-controlled clinical trial.C-reactive Protein: Repeated Measurements will Improve Dialysis Patient Care.Efficacy of Nutritional Interventions on Inflammatory Markers in Haemodialysis Patients: A Systematic Review and Limited Meta-Analysis.Does inflammation affect outcomes in dialysis patients?The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial
P2860
Q26797447-B6308E48-FB5D-4EB5-8371-B40E46BC5BDFQ27006939-4F92D1F8-D5C1-4863-8B62-3D49C6367CFAQ28074264-35DB3E81-6285-477B-870D-D7C8B33DAABDQ33666208-8DB71BF9-713B-430A-8F88-45D1B0C385C7Q33998131-C58ACE61-3233-4D96-AB6D-EE755D69F53DQ34493101-14BA39AA-6B0A-4815-B2A9-702C00425951Q34695324-DBE31527-05B6-42BE-9135-4E0EE5183119Q35128195-99EC3344-6121-42D5-8751-370C853ADCA9Q36232162-1E32F2A7-5CA8-4F0F-B698-E735C4E00FFDQ36640685-900A11A9-9641-4544-9671-96EC5D695915Q36753607-C2127138-39C9-4EC1-91FF-80CA426C38FEQ36914428-9BBF66DE-FDE1-4F70-89D3-3D6878BDAB88Q37571136-36A24872-3B68-4035-965C-BC3994D9A0C5Q37811885-99EEDD3C-75E7-4B26-848C-AE2A9A53A161Q38042223-372D4168-E472-4D3F-AFD3-2CA1CF5C9F9EQ38050186-31590C1F-9F38-42BC-9C7A-039213E987C5Q38075905-DB711665-B3DA-4895-9D51-1B4D57373843Q38185453-2C5C2E9B-FC1D-4E5C-9076-63CA6840A5DFQ38270746-8C401F2D-E30C-4C0D-BD4E-46C3B5140BA9Q38367160-D9AF4707-D0CD-42E5-AD2F-4FB91D4C6881Q38828450-96853843-A64F-46CE-AF52-BCF2C6599FEAQ39278083-EDF0C246-07A9-4381-94D5-7FBBFD901084Q42065495-653FDCE8-7E4F-4B5C-85DF-A919B92EBC8CQ43105925-46D85377-6FB5-45F5-ACF2-2C6774434599Q46001666-258188C3-450E-4F39-8491-58A6E5DA1738Q47152105-27D7E562-4813-437D-B722-0FDCBCA825FBQ47260247-FDAC18EE-37B9-4CDB-B40A-F55996D814EBQ48077990-23656538-21B8-411C-9910-E33333D00CC8Q48304928-250752A5-109F-4230-BB5F-8A8B679D8326Q48331973-647EE54E-3F12-4C2F-AC3F-40A50F436DFDQ51723059-4EBE3615-5B18-46D5-94A3-DE937247D617Q51736055-84CAEE9A-A20E-4097-93B3-037D87D26751Q52669320-F7CED813-AC28-4E21-A35A-A43EF6C4E2DAQ57684047-A42ED11D-18A0-495D-A7CC-B782C4957653
P2860
Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients.
@en
Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients.
@nl
type
label
Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients.
@en
Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients.
@nl
prefLabel
Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients.
@en
Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients.
@nl
P2093
P1476
Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients
@en
P2093
Ellen McMonagle
Guy Miller
Jonathan Himmelfarb
T Alp Ikizler
P304
P356
10.1053/J.JRN.2007.05.011
P577
2007-09-01T00:00:00Z